Ingenol mebutate clinical trials

Studies by the year they started

56 studies that test it; most in 2015 (8)

Who runs them

Industry 42 · Other 14

Peplin (25) · LEO Pharma (13) · Centre Hospitalier Universitaire de Nice (2) · Padagis LLC (2) · Actavis Inc. (2) · Icahn School of Medicine at Mount Sinai (2) · University of California, San Francisco (1) · University of Campania Luigi Vanvitelli (1)

Often tested with

Tested in the same studies.

Fluorouracil (2) · Diclofenac Sodium Gel (1) · Imiquimod (1)

Studies

Open first, then newest update. How each study uses ingenol mebutate is read from its arms, and is right about nine times in ten.

Testing it · 56

• Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the FaceCompletedPhase 2Centre Hospitalier Universitaire de NiceNCT02723721Written as Picato gel
• Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic KeratosisCompletedPhase 1/2LEO PharmaNCT01820260Written as Ingenol mebutate gel
• Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or ChestCompletedPhase 3LEO PharmaNCT02361216Written as Ingenol Mebutate
• Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and ScalpCompletedPhase 3LEO PharmaNCT01600014Written as Ingenol mebutate gel, 0.015%
• Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic KeratosisCompletedPhase 2LEO PharmaNCT01998984Written as ingenol mebutate
• Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%CompletedPhase 4LEO PharmaNCT01926496Written as Ingenol Mebutate Gel, 0.015%
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal MicroscopyCompletedPhase 1LEO PharmaNCT01449513Written as Ingenol mebutate
• Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use ConditionsCompletedPhase 1LEO PharmaNCT02124239Written as Ingenol mebutate
• Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or ScalpCompletedPhase 4LEO PharmaNCT02406014Written as Ingenol Mebutate Gel, 0.015%
• Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the ForearmCompletedPhase 1/2LEO PharmaNCT01803477Written as once daily for two consecutive days (Picato)
• Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%CompletedPhase 1LEO PharmaNCT01892137Written as Ingenol mebutate gel 0.05%
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by HistologyCompletedPhase 1LEO PharmaNCT01387711Written as PEP005 (Ingenol mebutat Gel, 0.05 %)
• A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/ExtremitiesCompletedPhase 3LEO PharmaNCT01787383Written as Ingenol mebutate gel 0.05 %
• Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital WartsCompletedPhase 2LEO PharmaNCT02377999Written as Picato
• Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell CarcinomaCompletedPhase 2Centre Hospitalier Universitaire de NiceNCT03546166Written as Picato 0.05% Topical Gel
• Picato for the Treatment of Molluscum Contagiosum in Immunocompromised PatientsWithdrawnEarly Phase 1Center for Clinical Studies, TexasNCT03336372Written as Picato
• Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant RecipientsCompletedPhase 4University of California, San FranciscoNCT02866695Written as ingenol mebutate gel 0.015%
• Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin LesionsWithdrawnEarly Phase 1Northwestern UniversityNCT01735942Written as Ingenol mebutate
• To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic KeratosisCompletedPhase 3Padagis LLCNCT02385318Written as Ingenol Mebutate (Perrigo)
• To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic KeratosisCompletedPhase 3Padagis LLCNCT02459795Written as Ingenol Mebutate (Perrigo)

See all 56 studies that test ingenol mebutate →

Codes

What other systems call ingenol mebutate · ClinicalTrials.gg INT004650

• UNII (FDA) 7686S50JAHINGENOL MEBUTATEConfirmed FDA, Wikidata
• RxNorm 1242806Confirmed FDA, Wikidata
• Wikidata Q426386ingenol mebutateConfirmed FDA, Wikidata
• NCI Thesaurus C48398Ingenol MebutateOne source FDA
• DrugBank DB05013One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.